SLC17A7 Gene

HGNC Family	Solute carriers (SLC)
Name	solute carrier family 17 (vesicular glutamate transporter), member 7
Description	The protein encoded by this gene is a vesicle-bound, sodium-dependent phosphate transporter that is specifically expressed in the neuron-rich regions of the brain. It is preferentially associated with the membranes of synaptic vesicles and functions in glutamate transport. The protein shares 82% identity with the differentiation-associated Na-dependent inorganic phosphate cotransporter and they appear to form a distinct class within the Na+/Pi cotransporter family. [provided by RefSeq, Jul 2008]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC17A7, which encodes vesicular glutamate transporter 1 (VGLUT1), is essential for accumulating glutamate into synaptic vesicles at presynaptic terminals. This uptake mechanism underlies the quantal release of glutamate—the brain’s main excitatory neurotransmitter—and is crucial for maintaining synaptic transmission and plasticity. Altered levels of VGLUT1, as evidenced by decreases in mRNA and protein in several brain regions, have been linked to deficits observed in schizophrenia, Alzheimer’s disease, and epilepsy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical role in excitatory neurotransmission, emerging evidence implicates SLC17A7/VGLUT1 in broader aspects of neuronal network organization and cellular homeostasis. Rare genetic variants in SLC17A7 have been detected in patients with schizophrenia, lending support to a multiple‐rare mutation contribution to the disorder’s pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Moreover, computational analyses have identified SLC17A7 as a bivalent tumor suppressor in gliomas, where its downregulation is associated with increased cell proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " Additionally, studies examining neural circuitry indicate that changes in VGLUT1 expression can affect the balance between excitatory and inhibitory signaling in specific brain regions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRecent findings also reveal that SLC17A7/VGLUT1 participates in regulating presynaptic architecture and synaptic vesicle dynamics. Structural modeling and simulation studies predict specific amino acid residues within its pore that determine glutamate and inhibitor binding"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ", while a proline‐rich domain in VGLUT1 mediates interactions with endocytic and scaffolding proteins—endophilinA1 and intersectin1—to enhance vesicle clustering and thereby modulate spontaneous release."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Furthermore, intracellular signaling pathways such as JNK‐mediated inhibition of insulin signaling have been shown to decrease VGLUT1 expression, which in turn exacerbates glutamatergic deficits and contributes to neuroinflammation, as observed in Alzheimer’s disease and following concussive injury."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S L Eastwood, P J Harrison "}, {"type": "b", "children": [{"type": "t", "text": "Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2004.05.010"}], "href": "https://doi.org/10.1016/j.schres.2004.05.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15653259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15653259"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "L Alonso-Nanclares, J De Felipe "}, {"type": "b", "children": [{"type": "t", "text": "Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroscience (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroscience.2005.03.038"}], "href": "https://doi.org/10.1016/j.neuroscience.2005.03.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15961236"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15961236"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Alireza Kashani, Eve Lepicard, Odile Poirel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2007.04.010"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2007.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17531353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17531353"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jonas Almqvist, Yafei Huang, Aatto Laaksonen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Docking and homology modeling explain inhibition of the human vesicular glutamate transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Sci (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1110/ps.072944707"}], "href": "https://doi.org/10.1110/ps.072944707"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17660252"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17660252"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Akin Oni-Orisan, Lars V Kristiansen, Vahram Haroutunian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2007.10.020"}], "href": "https://doi.org/10.1016/j.biopsych.2007.10.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18155679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18155679"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Akihito Uezato, James H Meador-Woodruff, Robert E McCullumsmith "}, {"type": "b", "children": [{"type": "t", "text": "Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bipolar Disord (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-5618.2009.00752.x"}], "href": "https://doi.org/10.1111/j.1399-5618.2009.00752.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19839996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19839996"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Samantha J Fung, Maree J Webster, Cynthia Shannon Weickert "}, {"type": "b", "children": [{"type": "t", "text": "Expression of VGluT1 and VGAT mRNAs in human dorsolateral prefrontal cortex during development and in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2011.03.004"}], "href": "https://doi.org/10.1016/j.brainres.2011.03.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21396926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21396926"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yu-Chih Shen, Ding-Lieh Liao, Jen-Yeu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2009.08.003"}], "href": "https://doi.org/10.1016/j.schres.2009.08.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19720501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19720501"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Biaoyang Lin, Hwahyung Lee, Jae-Geun Yoon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3030"}], "href": "https://doi.org/10.18632/oncotarget.3030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25749033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25749033"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Josef Gladitz, Barbara Klink, Michael Seifert "}, {"type": "b", "children": [{"type": "t", "text": "Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-018-0544-y"}], "href": "https://doi.org/10.1186/s40478-018-0544-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29890994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29890994"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Erik Hrabovszky, Csilla S Molnár, Róbert Nagy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glutamatergic and GABAergic innervation of human gonadotropin-releasing hormone-I neurons."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2011-2106"}], "href": "https://doi.org/10.1210/en.2011-2106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22510271"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22510271"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Javier Gilabert-Juan, Emilio Varea, Ramón Guirado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2012.09.032"}], "href": "https://doi.org/10.1016/j.neulet.2012.09.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23022470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23022470"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Xiao Min Zhang, Urielle François, Kätlin Silm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.50401"}], "href": "https://doi.org/10.7554/eLife.50401"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31663854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31663854"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Manuel Rodriguez-Perdigon, Maite Solas, Maria Javier Ramirez "}, {"type": "b", "children": [{"type": "t", "text": "JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-150659"}], "href": "https://doi.org/10.3233/JAD-150659"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26836159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26836159"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Stephanie A Madura, Jane K McDevitt, Ryan T Tierney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variation in SLC17A7 promoter associated with response to sport-related concussions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Inj (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/02699052.2016.1146958"}], "href": "https://doi.org/10.3109/02699052.2016.1146958"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27029226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27029226"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Manuel Rodriguez-Perdigon, Rosa María Tordera, Francisco Javier Gil-Bea, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hippocampus (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hipo.22607"}], "href": "https://doi.org/10.1002/hipo.22607"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27258819"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27258819"}]}]}]}
Synonyms	VGLUT1, BNPI
Proteins	VGLU1_HUMAN
NCBI Gene ID	57030
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

SLC17A7 has 7,151 functional associations with biological entities spanning 8 categories (molecular profile, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 118 datasets.

Click the + buttons to view associations for SLC17A7 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

SLC17A7 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Achilles Cell Line Gene Essentiality Profiles	cell lines with fitness changed by SLC17A7 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC17A7 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC17A7 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of SLC17A7 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of SLC17A7 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of SLC17A7 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of SLC17A7 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC17A7 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of SLC17A7 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of SLC17A7 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	small molecule perturbations changing expression of SLC17A7 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of SLC17A7 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC17A7 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with SLC17A7 gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC17A7 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of SLC17A7 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of SLC17A7 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	gene perturbations changing expression of SLC17A7 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of SLC17A7 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing SLC17A7 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing SLC17A7 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with SLC17A7 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with SLC17A7 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of SLC17A7 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with SLC17A7 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with SLC17A7 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	CTD Gene-Disease Associations	diseases associated with SLC17A7 gene/protein from the curated CTD Gene-Disease Associations dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by SLC17A7 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with SLC17A7 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with SLC17A7 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with SLC17A7 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with SLC17A7 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at SLC17A7 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC17A7 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of SLC17A7 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing SLC17A7 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
	GAD Gene-Disease Associations	diseases associated with SLC17A7 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
	GAD High Level Gene-Disease Associations	diseases associated with SLC17A7 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
	GDSC Cell Line Gene Expression Profiles	cell lines with high or low expression of SLC17A7 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
	GeneRIF Biological Term Annotations	biological terms co-occuring with SLC17A7 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.